secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ultragenyx Pharmaceutical Inc. (RARE)
CIK:        0001515673
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001193125-24-162003
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultragenyx raises ~$330.7M in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 7,435,898 shares at $39/share plus pre-funded warrants for 1,538,501 shares at $38.999.
- Net proceeds expected ~$330.7M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to 1,346,153 additional shares.
- Closing expected June 17, 2024; use of proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1515673/000119312524162003/0001193125-24-162003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1515673/000119312524162003/d785247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-162003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer